SLC20A1
| Symbol | SLC20A1 |
|---|---|
| HGNC ID | 10915 |
| Alternative symbols | – |
| Entrez Gene | 6574 |
| OMIM | 158378 |
| RefSeq | NM_005415 |
| UniProt | Q8WUM9 |
| Chromosome | 2q14 |
| Locus supplementary data | – |
SLC20A1 is a gene that encodes a protein known as the sodium-dependent phosphate transporter 1 (PiT-1). This protein is involved in the transport of phosphate ions across cell membranes, which is crucial for various cellular functions including metabolism, signal transduction, and nucleic acid synthesis.
Function[edit]
The SLC20A1 gene product, PiT-1, is a type III sodium-dependent phosphate transporter. It plays a significant role in maintaining phosphate homeostasis in the body. Phosphate is essential for bone mineralization, energy storage and release, and the regulation of acid-base balance in the body.
Clinical Significance[edit]
Mutations or dysregulation of the SLC20A1 gene can lead to disorders related to phosphate metabolism. Abnormal phosphate levels can result in conditions such as hyperphosphatemia or hypophosphatemia, which can affect bone health and lead to osteoporosis or rickets.
Expression[edit]
SLC20A1 is expressed in a wide range of tissues, indicating its fundamental role in cellular physiology. It is particularly important in tissues with high phosphate turnover, such as the kidney, intestine, and bone.
Interactions[edit]
The PiT-1 protein interacts with various other proteins and molecules to facilitate phosphate transport. It is regulated by factors such as parathyroid hormone and fibroblast growth factor 23 (FGF23), which are involved in phosphate homeostasis.
Research[edit]
Ongoing research is focused on understanding the precise mechanisms by which SLC20A1 regulates phosphate transport and its implications in disease states. Studies are also exploring potential therapeutic targets for conditions resulting from phosphate imbalance.
See Also[edit]
References[edit]
<references/>
External Links[edit]
| Genes on human chromosome 2 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian